Patents by Inventor Matthias Tschöp

Matthias Tschöp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tissue-specific exosomes as biomarkers
    Patent number: 11161902
    Abstract: In general, the present invention relates to the field of (bio-)medicine and in particular to various metabolic diseases. Specifically, the invention provides means and methods for diagnosing, monitoring and predicting the risk for developing metabolic diseases. The invention uses exosomes as biomarkers for the aforementioned purposes. Moreover, an antibody of the present invention capable of specifically recognizing tissue-specific exosomes is also provided.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: November 2, 2021
    Assignee: Helmholtz Zentrum Muenchen—Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (GmbH)
    Inventors: Kerstin Stemmer, Matthias Tschöp, Michaela Bauer, Reinhard Zeidler, Regina Feederle
  • Combination compositions and their use in methods for treating obesity and obesity-related disorders
    Patent number: 10568852
    Abstract: The present invention relates to compositions comprising at least two different active compounds and the use of such combination compositions in medicine, in particular in methods for treating obesity and obesity-related disorders and/or in methods for inhibiting weight gain.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: February 25, 2020
    Assignee: HELMHOLTZ ZENTRUM MUNCHEN - DEUTSCHES FORSCHUNGSZENTRUM FUR GESUNDHEIT UND UMWELT (GMBH)
    Inventors: Timo Dirk Mueller, Matthias Tschoep, Christoffer Clemmensen, Brian Finan
  • TISSUE-SPECIFIC EXOSOMES AS BIOMARKERS
    Publication number: 20190391163
    Abstract: In general, the present invention relates to the field of (bio-)medicine and in particular to various metabolic diseases. Specifically, the invention provides means and methods for diagnosing, monitoring and predicting the risk for developing metabolic diseases. The invention uses exosomes as biomarkers for the aforementioned purposes. Moreover, an antibody of the present invention capable of specifically recognizing tissue-specific exosomes is also provided.
    Type: Application
    Filed: May 9, 2017
    Publication date: December 26, 2019
    Inventors: Kerstin Stemmer, Matthias Tschöp, Michaela Bauer, Rienhard Zeidler, Regina Feederle
  • COMBINATION COMPOSITIONS AND THEIR USE IN METHODS FOR TREATING OBESITY AND OBESITY-RELATED DISORDERS
    Publication number: 20180147163
    Abstract: The present invention relates to compositions comprising at least two different active compounds and the use of such combination compositions in medicine, in particular in methods for treating obesity and obesity-related disorders and/or in methods for inhibiting weight gain.
    Type: Application
    Filed: May 23, 2016
    Publication date: May 31, 2018
    Inventors: Timo Dirk MUELLER, Matthias TSCHOEP, Christoffer CLEMMENSEN, Brian FINAN
  • Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
    Publication number: 20120079613
    Abstract: The present invention relates to the human homeobox transcription factor Bsx protein, nucleic acids encoding for said protein, vectors and cells comprising the nucleic acids, antibodies directed against Bsx, and methods for identifying compounds binding to Bsx, as well as to the use of proteins, nucleic acids, vectors, cells, and interacting compounds for treating obesity and related diseases.
    Type: Application
    Filed: April 2, 2007
    Publication date: March 29, 2012
    Applicants: Deutsches Institut fur Ernahrungsforschung (DIFE), European Molecular Biology Laboratory (EMBL)
    Inventors: Mathias Treier, Maria Sakkou, Petra Wiedmer, Matthias Tschoep